Paroxetine Use Throughout Pregnancy: Does It Pose Any Risk to the Neonate?
| Autor: | Iris Morag, Rimona Keidar, Eli Heyman, Mordechai Bulkowstein, D Batash |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
Adult
Male endocrine system Pediatrics medicine.medical_specialty Pregnancy High-Risk Health Toxicology and Mutagenesis Toxicology Lethargy Pregnancy medicine Humans Risk factor Fetus Crying Infant Newborn Abnormalities Drug-Induced Electroencephalography medicine.disease Paroxetine Hyperalgesia Maternal Exposure Anesthesia Gestation Female medicine.symptom Psychology Reuptake inhibitor Selective Serotonin Reuptake Inhibitors Maternal Age medicine.drug |
| Zdroj: | Journal of Toxicology: Clinical Toxicology. 42:97-100 |
| ISSN: | 0731-3810 |
| DOI: | 10.1081/clt-120028753 |
| Popis: | A newborn of a SSRI-treated mother presented with lethargy, no crying, and no response to tactile stimulation. EEG findings were abnormal. Laboratory and clinical evaluations were normal. He recovered at the age of two weeks. Serotonin is a neurotransmitter that has an important roll in pain modulation during fetal neurodevelopment. We suspect these symptoms are attributed to the intrauterine exposure to paroxetine, through modulation of pain signals. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|